DNMT3A mutations in TBRS patients have been found to affect the protein’s functional domains, and it has been suggested this may impair histone binding and domain–domain interactions [154]. This evidence concerns the gene DNMT3A and Tatton-Brown-Rahman overgrowth syndrome.